NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $715,789 | -2.6% | 7,027 | -3.5% | 0.07% | -8.2% |
| Q2 2023 | $734,846 | +1.3% | 7,282 | -7.7% | 0.07% | -7.6% |
| Q1 2023 | $725,579 | -15.7% | 7,887 | -16.9% | 0.08% | -23.3% |
| Q4 2022 | $860,547 | +17.9% | 9,486 | -1.2% | 0.10% | +9.6% |
| Q3 2022 | $730,000 | -9.8% | 9,602 | +0.3% | 0.09% | -9.6% |
| Q2 2022 | $809,000 | -5.0% | 9,574 | -1.4% | 0.10% | +23.8% |
| Q1 2022 | $852,000 | -0.1% | 9,706 | -0.5% | 0.08% | -5.6% |
| Q4 2021 | $853,000 | +3.0% | 9,751 | -3.6% | 0.09% | -12.7% |
| Q3 2021 | $828,000 | -8.5% | 10,120 | +2.0% | 0.10% | -15.0% |
| Q2 2021 | $905,000 | +0.4% | 9,923 | -5.9% | 0.12% | -12.4% |
| Q1 2021 | $901,000 | -17.6% | 10,540 | -8.9% | 0.14% | -27.9% |
| Q4 2020 | $1,093,000 | -8.1% | 11,572 | -15.4% | 0.19% | -17.4% |
| Q3 2020 | $1,189,000 | -14.6% | 13,678 | -14.2% | 0.23% | -27.4% |
| Q2 2020 | $1,392,000 | +13.8% | 15,941 | +7.4% | 0.32% | -7.0% |
| Q1 2020 | $1,223,000 | – | 14,845 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |